Tybourne Capital Management’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.91M | Buy |
993,743
+417,400
| +72% | +$2.9M | 20% | 3 |
|
|
2025
Q1 | $4.89M | Sell |
576,343
-693,192
| -55% | -$5.89M | 20.77% | 3 |
|
|
2024
Q4 | $17.8M | Sell |
1,269,535
-125,000
| -9% | -$1.75M | 4.46% | 9 |
|
|
2024
Q3 | $31.6M | Sell |
1,394,535
-115,178
| -8% | -$2.61M | 8.85% | 6 |
|
|
2024
Q2 | $30.6M | Sell |
1,509,713
-35,313
| -2% | -$715K | 6.21% | 9 |
|
|
2024
Q1 | $38.5M | Sell |
1,545,026
-105,294
| -6% | -$2.62M | 6.58% | 5 |
|
|
2023
Q4 | $29.8M | Buy |
1,650,320
+368,500
| +29% | +$6.66M | 4.45% | 11 |
|
|
2023
Q3 | $25.8M | Hold |
1,281,820
| – | – | 3.6% | 12 |
|
|
2023
Q2 | $32.7M | Sell |
1,281,820
-127,011
| -9% | -$3.24M | 3.54% | 12 |
|
|
2023
Q1 | $30M | Buy |
1,408,831
+503,109
| +56% | +$10.7M | 3.02% | 13 |
|
|
2022
Q4 | $26.8M | Sell |
905,722
-135,609
| -13% | -$4.01M | 2.67% | 16 |
|
|
2022
Q3 | $24.2M | Sell |
1,041,331
-112,795
| -10% | -$2.62M | 2.33% | 19 |
|
|
2022
Q2 | $19.4M | Hold |
1,154,126
| – | – | 1.4% | 23 |
|
|
2022
Q1 | $50.6M | Sell |
1,154,126
-899,678
| -44% | -$39.5M | 3% | 18 |
|
|
2021
Q4 | $125M | Buy |
2,053,804
+95,843
| +5% | +$5.83M | 3.71% | 13 |
|
|
2021
Q3 | $81.4M | Hold |
1,957,961
| – | – | 2.05% | 16 |
|
|
2021
Q2 | $59.4M | Hold |
1,957,961
| – | – | 1.25% | 20 |
|
|
2021
Q1 | $58.5M | Hold |
1,957,961
| – | – | 1.28% | 23 |
|
|
2020
Q4 | $35.1M | Hold |
1,957,961
| – | – | 0.73% | 27 |
|
|
2020
Q3 | $37.3M | Hold |
1,957,961
| – | – | 0.92% | 25 |
|
|
2020
Q2 | $30.8M | Hold |
1,957,961
| – | – | 0.94% | 20 |
|
|
2020
Q1 | $26.7M | Hold |
1,957,961
| – | – | 0.98% | 20 |
|
|
2019
Q4 | $18.5M | Hold |
1,957,961
| – | – | 0.71% | 13 |
|
|
2019
Q3 | $22.3M | Hold |
1,957,961
| – | – | 0.97% | 11 |
|
|
2019
Q2 | $19.7M | Buy |
+1,957,961
| New | +$19.7M | 0.7% | 13 |
|